Viewing Study NCT04475159


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-02-01 @ 10:09 PM
Study NCT ID: NCT04475159
Status: UNKNOWN
Last Update Posted: 2020-07-17
First Post: 2020-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial
Sponsor: Prof. Aviram Nissan
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
None Peritoneal Carcinomatosis View
None Colon Adenocarcinoma View
Keywords: